Literature DB >> 8314577

Sequence of the murine factor VIII cDNA.

B Elder1, D Lakich, J Gitschier.   

Abstract

DNA clones corresponding to the mouse homolog of the human factor VIII gene have been isolated and sequenced. The murine gene is expressed in most tissues examined and the mRNA is approximately 1.8 kb smaller than the human transcript, primarily due to a shorter 3' untranslated region. The mouse cDNA encodes a protein of 2319 amino acids, 32 amino acids shorter than human factor VIII, with 74% identity to the human sequence. Further comparison shows that amino acid sequences in the functionally important A and C domains are highly conserved (84-93% identity), whereas the B domains and the two acidic domains are more divergent (42-70% identity). All thrombin/factor Xa cleavages sites and all but one activated protein C cleavage site are conserved in mouse factor VIII, as well as a tyrosine residue needed for von Willebrand factor binding. These findings suggest that mouse factor VIII operates in the clotting cascade much like the human protein, but reveal some differences that may have functional significance.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8314577     DOI: 10.1006/geno.1993.1200

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  16 in total

1.  Covalent genomic DNA modification patterns revealed by denaturing gradient gel blots.

Authors:  Shari L Laprise; Mark R Gray
Journal:  Gene       Date:  2006-12-12       Impact factor: 3.688

Review 2.  Highly conserved antigenic structure of the factor VIII C2 domain in some mammals.

Authors:  Jun-ichi Ori; Ichiro Tanaka; Yoko Kubota; Midori Shima; Tomoko Matsumoto; Koichi Yoshida; Yoshihiko Sakurai; Akira Yoshioka
Journal:  Int J Hematol       Date:  2005-11       Impact factor: 2.490

3.  Comparison of the human and murine ATRX gene identifies highly conserved, functionally important domains.

Authors:  D J Picketts; A O Tastan; D R Higgs; R J Gibbons
Journal:  Mamm Genome       Date:  1998-05       Impact factor: 2.957

4.  Native-like aggregates of factor VIII are immunogenic in von Willebrand factor deficient and hemophilia a mice.

Authors:  Dipak S Pisal; Matthew P Kosloski; C Russell Middaugh; Richard B Bankert; Sathy V Balu-Iyer
Journal:  J Pharm Sci       Date:  2012-03-02       Impact factor: 3.534

5.  Factor VIII associated with lipidic nanoparticles retains efficacy in the presence of anti-factor VIII antibodies in hemophilia A mice.

Authors:  Krithika A Shetty; Matthew P Kosloski; Donald E Mager; Sathy V Balu-Iyer
Journal:  Biopharm Drug Dispos       Date:  2016-09-13       Impact factor: 1.627

Review 6.  Animal models of hemophilia.

Authors:  Denise E Sabatino; Timothy C Nichols; Elizabeth Merricks; Dwight A Bellinger; Roland W Herzog; Paul E Monahan
Journal:  Prog Mol Biol Transl Sci       Date:  2012       Impact factor: 3.622

7.  Detection of mutations in ectopic factor VIII transcripts from nine haemophilia A patients and the correlation with phenotype.

Authors:  S I Bidichandani; W G Lanyon; C R Shiach; G D Lowe; J M Connor
Journal:  Hum Genet       Date:  1995-05       Impact factor: 4.132

8.  Role of glycosylation in conformational stability, activity, macromolecular interaction and immunogenicity of recombinant human factor VIII.

Authors:  Matthew P Kosloski; Razvan D Miclea; Sathy V Balu-Iyer
Journal:  AAPS J       Date:  2009-06-05       Impact factor: 4.009

9.  Characterization of cDNA for murine tripeptidyl-peptidase II reveals alternative splicing.

Authors:  B Tomkinson
Journal:  Biochem J       Date:  1994-12-01       Impact factor: 3.857

10.  Intracellular retention of a factor VIII protein with an Arg2307-->Gln mutation as a cause of haemophilia A.

Authors:  J Voorberg; R T de Laaf; P M Koster; J A van Mourik
Journal:  Biochem J       Date:  1996-09-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.